The first phase 3 trials are due to start in the first half of next year, using devices manufactured at GSK’s facility in Evreux, France. “If successful, this could lead to regulatory ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other cheapest stocks with biggest upside potential. Stocks rallied on January 15, following an encouraging ...

It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024. GSK has increased its long-term sales guidance amid hopes for a boost from new speciality medicines ...